Explore
Search
Learn
Watch
Portfolio
KURA
Kura Oncology, Inc.
Healthcare
$9.61
+3.5%
1Y
$9.61
$7.40
52 weeks
$13.59
KURA
Kura Oncology, Inc.
$9.61
+3.50%
1Y
Overview
RyuScore
Safety
Valuation
Market
Financials
Ownership
Latest close: below its 200-day average
Oct 23, 2026
what changed →
Who owns it
opening the register…
More on Kura Oncology, Inc.
KURA overview
Price, RyuScore, the earnings flow and the five questions at a glance.
KURA revenue and segments
The quarter as a flow, the full statements, and what the business is made of.
KURA financial charts
Every reported figure as its own chart, quarterly and trailing twelve months.
Is KURA financially safe?
Distress and accounting checks, debt cover, drawdowns and factor exposure.
Is KURA overvalued?
What the price assumes, its own history, peer multiples and a fair-value range.
KURA price history
Trend and momentum, key levels, total return, seasonality.
KURA SEC filings and events
The company's own record, every flag beside its market-wide base rate.
Biotechnology
Ranks
#101
of 194 by RyuScore
Compare peers
Random peer
ANRO
-0.81%
Alto Neuroscience, Inc.
SVRA
-7.1%
Savara Inc.
AKTS
-6.2%
Aktis Oncology, Inc.
HELP
-2.7%
Cybin
ABUS
-0.24%
Arbutus Biopharma Corp
ALMS
-0.15%
Alumis Inc.